We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

93 hedge funds and large institutions have $464M invested in Abeona Therapeutics in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 34 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 9

42% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 24

39% more capital invested

Capital invested by funds: $335M → $464M (+$130M)

24% more funds holding

Funds holding: 75 → 93 (+18)

0.56% more ownership

Funds ownership: 1.95% → 2.5% (+0.56%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

28% less call options, than puts

Call options by funds: $4.63M | Put options by funds: $6.47M

Holders
93
Holders Change
+18
Holders Change %
+24%
% of All Funds
2.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
34
Reduced
24
Closed
9
Calls
$4.63M
Puts
$6.47M
Net Calls
-$1.84M
Net Calls Change
-$24.8M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$64.6M
2
State Street
State Street
Massachusetts
+$31.7M
3
Viking Global Investors
Viking Global Investors
Connecticut
+$29.8M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$21.3M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$8.69M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$23.6M
2
PC
PointState Capital
New York
-$6.45M
3
Barclays
Barclays
United Kingdom
-$2.98M
4
CHP
Castle Hook Partners
New York
-$2.97M
5
Deutsche Bank
Deutsche Bank
Germany
-$1.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$2.26M -$1.57M -3,798 -40%
RA
27
Royce & Associates
New York
$2.25M -$1.41M -3,400 -37%
Deutsche Bank
28
Deutsche Bank
Germany
$2.16M -$1.83M -4,426 -45%
Citigroup
29
Citigroup
New York
$1.86M +$318K +768 +20%
UBS Group
30
UBS Group
Switzerland
$1.77M -$160K -386 -8%
Allianz Asset Management
31
Allianz Asset Management
Germany
$1.62M -$21.9K -53 -1%
MCM
32
Moore Capital Management
New York
$1.58M +$1.24M +3,000 +300%
Goldman Sachs
33
Goldman Sachs
New York
$1.37M -$942K -2,277 -40%
BGIM
34
Brandywine Global Investment Management
Pennsylvania
$1.28M -$146K -354 -10%
Ameriprise
35
Ameriprise
Minnesota
$1.13M +$1.18M +2,857 New
TCIM
36
TIAA CREF Investment Management
New York
$1.05M -$25.6K -62 -2%
CT
37
Cambridge Trust
Massachusetts
$1.04M – – –
PA
38
Perceptive Advisors
New York
$946K -$947K -2,290 -49%
PPA
39
Parametric Portfolio Associates
Washington
$921K +$962K +2,325 New
Charles Schwab
40
Charles Schwab
California
$894K +$252K +610 +37%
EGI
41
EAM Global Investors
California
$858K +$896K +2,166 New
TA
42
Teachers Advisors
New York
$816K +$117K +284 +16%
Swiss National Bank
43
Swiss National Bank
Switzerland
$794K +$829K +2,004 New
Wells Fargo
44
Wells Fargo
California
$738K +$187K +452 +32%
AQR Capital Management
45
AQR Capital Management
Connecticut
$721K +$24.4K +59 +3%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$703K +$93K +225 +15%
AAP
47
Ardsley Advisory Partners
Connecticut
$634K -$165K -400 -20%
Alkeon Capital Management
48
Alkeon Capital Management
New York
$634K +$662K +1,600 New
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$557K +$582K +1,407 New
CS
50
Credit Suisse
Switzerland
$529K +$155K +376 +39%
1
2
3 4 5

ABEO Hedge Fund Activity: Q4 2017 in Review

93 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q4 2017, worth a combined $464M — up 39% from $335M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ABEO positions and 9 closed out — a net gain of 18 holders — while 34 added to existing stakes and 24 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $64.6M. The largest seller was Citadel Advisors, cutting an estimated $23.6M.

  • 93 institutional investors held Abeona Therapeutics (ABEO) as of Q4 2017, up from 75 in Q3 2017.
  • Funds reported $464M of Abeona Therapeutics stock for Q4 2017, up 39% quarter-over-quarter.
  • 27 funds opened new Abeona Therapeutics positions in Q4 2017 and 9 closed out, a net change of +18 holders.
  • The largest Abeona Therapeutics buyer in Q4 2017 was Fidelity Investments, an estimated $64.6M added.
  • The largest Abeona Therapeutics seller in Q4 2017 was Citadel Advisors, an estimated $23.6M sold.

Based on aggregated 13F filings for Q4 2017.